Atlas Trials

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Clinical trial NCT00150449 · COMPLETED

Trial details

NCT number
NCT00150449
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Anxiety Neuroses
Start date
2001-01-01
Enrollment
511

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.